Neovasc Announces $11.5 Million Registered Direct Offering Priced At-The-Market
June 12, 2020 09:00 ET
|
Neovasc, Inc.
Vancouver, BC, June 12, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN / TSX: NVCN) announced today that it has entered into definitive...
Neovasc Announces Closing of Final Convertible Debt Issuance for Gross Proceeds of US$5.0 Million
June 04, 2020 09:00 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, MN, June 04, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally...
Neovasc Reducer Spotlighted in Leading German Public Television Program
June 03, 2020 09:53 ET
|
Neovasc, Inc.
Elective Interventional Procedures Resume in Germany VANCOUVER and MINNEAPOLIS, MN, June 03, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX:...
Neovasc Has Filed for CE Mark for Tiara TA Transapical Mitral Valve Replacement System
May 27, 2020 09:42 ET
|
Neovasc, Inc.
Less invasive approach provides hope for the millions of patients that suffer from leaky mitral valves VANCOUVER and MINNEAPOLIS, MN, May 27, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE...
Neovasc Announces First Quarter Financial Results
May 07, 2020 16:05 ET
|
Neovasc, Inc.
Promotes John Panton to Chief Quality Officer VANCOUVER and MINNEAPOLIS, MN, May 07, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Neovasc Inc. ("Neovasc" or the "Company")...
Neovasc to Report First Quarter Financial Results on May 7, 2020
April 23, 2020 08:30 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, MN, April 23, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve...
Neovasc to Participate in SVB Leerink 9th Annual Global Healthcare Conference on February 26, 2020
February 18, 2020 09:00 ET
|
Neovasc, Inc.
VANCOUVER, Feb. 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter...
Neovasc Initiates Independent Inquiry Into Trading of its Shares
February 11, 2020 07:30 ET
|
Neovasc, Inc.
Vancouver, Feb. 11, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter...
Neovasc Announces Renewal of German Reimbursement NUB Status 1 Designation for Neovasc Reducer for Treatment of Refractory Angina
January 31, 2020 09:00 ET
|
Neovasc, Inc.
Participating Hospitals in Germany Now Eligible to Negotiate Reimbursement for Reducer Procedure VANCOUVER, Jan. 31, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. ("Neovasc" or...
Neovasc Announces Executive Steering Committee for Transfemoral Trans-septal Tiara Program
January 28, 2020 09:00 ET
|
Neovasc, Inc.
VANCOUVER, Jan. 28, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter...